Structure Therapeutics (GPCR) Operating Leases (2023 - 2026)
Structure Therapeutics (GPCR) posted quarterly Operating Leases of $3.2 million for Q1 2026, down 37.78% year-over-year from $5.1 million in Q1 2025, and down 11.8% quarter-over-quarter from $3.6 million in Q4 2025.
Structure Therapeutics (GPCR) Operating Leases (2023 - 2026) Analysis & Trends
Structure Therapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Operating Leases fell 37.78% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 37.78% YoY), while the FY2025 annual figure was $3.6 million, up 66.77% from the prior year.
- Operating Leases for Q1 2026 stood at $3.2 million, down from $3.6 million in the prior quarter.
- The five-year high for Operating Leases was $5.1 million in Q1 2025, with the low at $2.2 million in Q4 2024.
- The 4-year median for Operating Leases is $3.5 million (2024), against an average of $3.6 million.
- The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 46.08% in 2024, then surged 66.77% in 2025.
- Structure Therapeutics' Operating Leases stood at $4.0 million in 2023, then plunged by 46.08% to $2.2 million in 2024, then soared by 66.77% to $3.6 million in 2025, then declined by 11.8% to $3.2 million in 2026.
- Business Quant data shows GPCR's Operating Leases at $3.2 million in Q1 2026, $3.6 million in Q4 2025, and $4.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Structure Therapeutics | 11.65 Bn | 11.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.63 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 4.29 Mn |
| Jun 30, 2025 | 5.01 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 4.01 Mn |
| Sep 30, 2023 | 3.03 Mn |